Roche Drug

With the launch of the new drug, the global pharma company hopes to expand its neurology portfolio and cater to the untapped need of patients facing the disease in India

Can Roche stay ahead of the competition in the next 125 years?

Pharma giant Roche believes, its ability to reinvent itself through innovation was behind its success. Business Standard's Sohini Das and Nivedita Mookerji spoke to the members of its founding family

'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'

Drug firm Roche India said it has received Emergency Use Authorisation from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail

Co says demand for tocilizumab may exceed supplies it can provide

Tocilizumab, sold under the brand name Actemra, is an intravenous anti-inflammatory monoclonal antibody drug used to treat rheumatoid arthritis

Some firms are now considering starting their own distribution centres in major cities

The Federal Trade Commission (FTC) and Britain's Competition and Markets Authority (CMA) approved the deal on Monday without demanding asset sales

The US Food and Drug Administration granted priority review for risdiplam, an oral medicine for those with the potentially deadly muscle-wasting disorder

Drug firm Roche Wednesday said it has partnered with Wellthy Therapeutics to offer users of the Accu-Chek Active system an artificial intelligence-based digital diabetes coaching solution. The joint offering of the two companies will encompass Accu-Chek Active blood glucose meter and the Wellthy Care app to the new users. The bundle is being launched in the south as well western parts of the country. "With Wellthy's digital diabetes health coach, new Accu-Chek Active users can log blood glucose readings into the app to receive 24/7 guidance on understanding and managing their diabetes better. We firmly believe that this joint offering will help in improving the quality of life for Indians living with type 2 diabetes," Roche Diabetes Care India Ad-Interim General Manager Rahul Kedia said. Wellthy Therapeutics Co-Founder & CEO Abhishek Shah said the partnership marks an important first step, in a larger shared vision to make a meaningful difference to the lives of millions of people

Roche's November announcement that its Impower 150 trial had broadly succeeded in first-line lung cancer patients